BMAL1 in cardiovascular diseases: Molecular mechanisms, circadian regulation and translational perspectives (Review)
Current evidence does not support viewing BMAL1 as simply protective or harmful, and small-molecule clock modulators, chronotherapy and non-pharmacological interventions, as well as time-resolved multi-omics and machine-learning approaches are assessed.